Overview
Zheyuan Technology provides AI pharmaceutical R&D solutions. Incubated by the Chinese Academy of Sciences’ Institute of Computing Technology, it is a platform company using digital life technology for pharmaceutical innovation. Its digital twins of life functions systematically propose new tumor targets, evaluate promising indications and predict responding patients. It aims to build a digital drug testing ground that overcomes biochemical bottlenecks, improves drug R&D productivity, clinical trial success and treatment effectiveness, and introduces a new R&D paradigm to protect human health. It holds high-value intellectual property in new targets, indications and companion diagnostics.
Connected profiles
Explore
More Health management products
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
哲源科技是一家AI医药研发解决方案提供商，是一家由中国科学院计算技术研究所孵化的，以数字生命技术赋能医药创新的平台型公司。 公司拥有生命功能的数字孪生技术，实现系统性递呈肿瘤新靶点，精准评估优势适应症，精准预测响应患者。哲源致力于构建“药物数字试验场”，突破生化技术的瓶颈，提升药物研发效能、临床试验成功率、临床治疗有效率，为医药研发引入新范式，为人类健康保驾护航。目前，公司已经拥有新靶点、新适应症、药物伴随诊断等多项高价值IP。